These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34263381)

  • 1. Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis.
    Kim ES; Kim KO; Jang BI; Kim EY; Lee YJ; Lee HS; Lee JS; Kim SK; Jung YJ; Kang SB; Agrawal M; Ungaro R; Colombel JF
    Dig Dis Sci; 2022 Jul; 67(7):2866-2875. PubMed ID: 34263381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis.
    Le Baut G; Kirchgesner J; Amiot A; Lefevre JH; Chafai N; Landman C; Nion I; Bourrier A; Delattre C; Martineau C; Sokol H; Seksik P; Nguyen Y; Marion Y; Lebreton G; Carbonnel F; Viennot S; Beaugerie L;
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1602-1610.e1. PubMed ID: 31927106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults.
    Subhaharan D; Ramaswamy PK; Willmann L; Moattar H; Bhullar M; Ishaq N; Dorrington A; Shukla D; McIvor C; Edwards J; Mohsen W
    World J Gastroenterol; 2023 Apr; 29(16):2469-2478. PubMed ID: 37179589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.
    Lee HS; Yang SK; Soh JS; Lee S; Bae JH; Lee HJ; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Inflamm Bowel Dis; 2015 Aug; 21(8):1825-31. PubMed ID: 25985248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study.
    Huang D; Rennie M; Krasovec A; Nagubandi S; Liu S; Ge E; Khehra B; Au M; Sivagnanam S; Kwan V; Rogge C; Mitrev N; Kariyawasam V
    Ther Adv Chronic Dis; 2024; 15():20406223241233203. PubMed ID: 38560721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
    Sebastian S; Walker GJ; Kennedy NA; Conley TE; Patel KV; Subramanian S; Kent AJ; Segal JP; Brookes MJ; Bhala N; Gonzalez HA; Hicks LC; Mehta SJ; Lamb CA;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):271-281. PubMed ID: 33545083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
    Berinstein JA; Sheehan JL; Dias M; Berinstein EM; Steiner CA; Johnson LA; Regal RE; Allen JI; Cushing KC; Stidham RW; Bishu S; Kinnucan JAR; Cohen-Mekelburg SA; Waljee AK; Higgins PDR
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2112-2120.e1. PubMed ID: 34048936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of emergency colectomy in patients admitted with acute severe ulcerative colitis.
    Mokhele NN; Thomson SR; Watermeyer GA
    S Afr J Surg; 2017 Sep; 55(3):20-26. PubMed ID: 28876561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRAB score for prediction of colectomy within 2 years following admission for acute severe ulcerative colitis.
    Devadas K; Giri S; Varghese J; George A
    Saudi J Gastroenterol; 2023; 29(5):295-299. PubMed ID: 37040219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China.
    Liu X; Li H; Tian F; Xie Y; Zhang X; Zhi M; Zhang M; Song X; Guo H; Li X; Liang J; Shen J; Li Y
    Gastroenterol Rep (Oxf); 2024; 12():goae051. PubMed ID: 38855349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.
    Lee HS; Park SH; Kim SH; Kim J; Choi J; Lee HJ; Kim WS; Lee JM; Kwak MS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH; Yang SK
    Inflamm Bowel Dis; 2016 Apr; 22(4):912-8. PubMed ID: 26829410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
    Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
    Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative Colitis.
    Wu HM; Wei J; Li J; Wang K; Ye L; Qi Y; Yuan BS; Yang YL; Zhao L; Yang Z; Yang MF; Gong JF; Wang FY
    Dig Dis Sci; 2019 Nov; 64(11):3263-3273. PubMed ID: 30604378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis.
    Oh SJ; Shin GY; Soh H; Lee JG; Im JP; Eun CS; Lee KM; Park DI; Han DS; Kim HJ; Lee CK
    Intest Res; 2021 Jul; 19(3):323-331. PubMed ID: 32806875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study.
    Sebastian S; Patel KV; Segal JP; Subramanian S; Conley TE; Gonzalez HA; Kent AJ; Saifuddin A; Hicks L; Mehta S; Bhala N; Brookes MJ; Lamb CA; Kennedy NA; ; Walker GJ
    BMJ Open Gastroenterol; 2022 Jan; 9(1):. PubMed ID: 35101886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Govani SM; Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Hardiman KM
    Dig Dis Sci; 2020 Jun; 65(6):1800-1805. PubMed ID: 31748921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy.
    Powar MP; Martin P; Croft AR; Walsh A; Petersen D; Stevenson AR; Lumley JW; Stitz RW; Radford-Smith GL; Clark DA
    Colorectal Dis; 2013 Mar; 15(3):374-9. PubMed ID: 22849324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients admitted with acute, severe ulcerative colitis on biologic therapy: a retrospective analysis from a tertiary referral hospital.
    Sabrie N; Jogendran M; Jogendran R; Targownik LE
    J Can Assoc Gastroenterol; 2024 Aug; 7(4):306-311. PubMed ID: 39139222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.